Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stibium Metallicum Praeparatum D6 for Reducing Chemotherapy-induced Peripheral Neuropathy
NCT04715542Phase 3Not yet recruiting
- Sponsor
- University of Bern
- Start
- Jan 2027
- Primary completion
- Jan 2029
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of stibium metallicum praeparatum in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by University of Bern. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
stibium metallicum praeparatum
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04715542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04715542.